A Study of LAM-002A for the Prevention of Progression of COVID-19

Clinical trial NCT04446377 · COMPLETED

Trial details

NCT number: NCT04446377
Sponsor: OrphAI Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Disease

Start date: 2020-07-15
Primary completion: 2021-03-24
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.